Sörensen BT - Search Results

1

A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.

Sorbe BG, Högberg T, Glimelius B, Schmidt M, Wernstedt L, Hansen O, Sörensen BT, Räisänen I, van Oosterom AT, de Bruijn KM. Sorbe BG, et al. Among authors: sorensen bt. Cancer. 1994 Jan 15;73(2):445-54. doi: 10.1002/1097-0142(19940115)73:2<445::aid-cncr2820730233>3.0.co;2-4. Cancer. 1994. PMID: 8293412 Clinical Trial.

2

Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. The Nordic Antiemetic Trial Group.

Sorbe BG, Högberg T, Glimelius B, Schmidt M, Wernstedt L, Andersson H, Hansen O, Sørensen BT, Räisänen I. Sorbe BG, et al. Among authors: sorensen bt. Anticancer Drugs. 1995 Feb;6 Suppl 1:31-6. Anticancer Drugs. 1995. PMID: 7749168 Clinical Trial.

3

The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer.

Sørensen B, Bastholt L, Mirza MR, Gjedde SB, Jakobsen P, Mouridsen HT, Rose C. Sørensen B, et al. Cancer Chemother Pharmacol. 1994;34(5):439-43. doi: 10.1007/BF00685571. Cancer Chemother Pharmacol. 1994. PMID: 8070013 Clinical Trial.

4

A limited sampling method for estimation of the etoposide area under the curve.

Strömgren AS, Sørensen BT, Jakobsen P, Jakobsen A. Strömgren AS, et al. Among authors: sorensen bt. Cancer Chemother Pharmacol. 1993;32(3):226-30. doi: 10.1007/BF00685840. Cancer Chemother Pharmacol. 1993. PMID: 7684658

5

Treatment of extensive small cell lung cancer with carboplatin and teniposide.

Sørensen BT, Nielsen K, Steenholdt S, Schultz H, Jakobsen A. Sørensen BT, et al. Eur J Cancer. 1991;27(9):1109-12. doi: 10.1016/0277-5379(91)90304-v. Eur J Cancer. 1991. PMID: 1659851 Clinical Trial.

6

Renal handling of carboplatin.

Sørensen BT, Strömgren A, Jakobsen P, Nielsen JT, Andersen LS, Jakobsen A. Sørensen BT, et al. Cancer Chemother Pharmacol. 1992;30(4):317-20. doi: 10.1007/BF00686302. Cancer Chemother Pharmacol. 1992. PMID: 1643701

7

A limited sampling method for estimation of the carboplatin area under the curve.

Sørensen BT, Strömgren A, Jakobsen P, Jakobsen A. Sørensen BT, et al. Cancer Chemother Pharmacol. 1993;31(4):324-7. doi: 10.1007/BF00685679. Cancer Chemother Pharmacol. 1993. PMID: 8422698

8

The pharmacokinetics of high-dose epirubicin and of the cardioprotector ADR-529 given together with cyclophosphamide, 5-fluorouracil, and tamoxifen in metastatic breast-cancer patients.

Jakobsen P, Sørensen B, Bastholt L, Mirza MR, Gjedde SB, Mouridsen HT, Rose C. Jakobsen P, et al. Cancer Chemother Pharmacol. 1994;35(1):45-52. doi: 10.1007/BF00686283. Cancer Chemother Pharmacol. 1994. PMID: 7987976 Clinical Trial.

9

Dose-toxicity relationship of carboplatin in combination with cyclophosphamide in ovarian cancer patients.

Sørensen BT, Strömgren A, Jakobsen P, Jakobsen A. Sørensen BT, et al. Cancer Chemother Pharmacol. 1991;28(5):397-401. doi: 10.1007/BF00685696. Cancer Chemother Pharmacol. 1991. PMID: 1914085

10

Changes in thymidylate synthase mRNA in blood leukocytes from patients with colorectal cancer after bolus administration of 5-fluorouracil.

Ehrnrooth E, Sørensen B, Poulsen JH, Sørensen BS, von der Maase H. Ehrnrooth E, et al. Acta Oncol. 2000;39(1):53-7. doi: 10.1080/028418600430978. Acta Oncol. 2000. PMID: 10752654

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters